Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-19-041911

Head of Development & CMO sold 18,000 shares at $21.11 ($379,903)

  • Head of Development & CMO acquired 18,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GUALBERTO ANTONIO · Head of Development & CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-10 Exercise or conversion : show line 1 in the form +18,000 $6.15 $110,700 357,973 D
2019-07-10 Sale : show line 2 in the form −18,000 $21.11 $379,903 339,973 D
Open-market sales · 18,000 sh · avg $21.11 · $379,903

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-07-10 Exercise or conversion : show line 3 in the form Option to purchase common stock −18,000 $6.15 2027-01-22 18,000 151,000 D
Loading xslF345X03/doc4.xml…